Aquestive Therapeutics
AQST
#7659
Rank
A$0.65 B
Marketcap
A$5.23
Share price
-6.61%
Change (1 day)
-40.98%
Change (1 year)

Earnings for Aquestive Therapeutics (AQST)

Earnings in 2026 (TTM): -A$94.27 Million

According to Aquestive Therapeutics 's latest financial reports the company's current earnings are A$48.83 Million. In 2025 the company made an earning of -A$0.11 Billion a decrease over its 2024 earnings that were of -A$41.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aquestive Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$94.27 Million-6.43%
2025 -A$0.11 Billion143.96%
2024 -A$41.3 Million16669.33%
2023 -A$0.25 Million-99.61%
2022 -A$63.4 Million-12.56%
2021 -A$72.51 Million12.24%
2020 -A$64.61 Million-24.89%
2019 -A$86.01 Million6.04%
2018 -A$81.12 Million4243.61%
2017 -A$1.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.25 Billion 147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.44 Million-71.78%๐Ÿ‡บ๐Ÿ‡ธ USA